Thoughts on DESTINY-Breast04 for HER2-low metastatic breast cancer.
Joseph GLIGOROV
Oncologist, Paris, France
Oncologist, Paris, France
New User? Click here to register
Text generated by AI based on an exclusive interview, revised and reviewed by
Foucauld CHAMMING'S
15.00 I 15.15
Didier BOURGEOIS
Dalila AHNOU
Didier Bourgeois
Chirurgien cancérologue spécialisé en sénologie et gynécologie
à l’Institut du Sein Henri Hartmann, Neuilly Sur Seine, France
Copyright © 2026 - BCU